+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Sale

Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • TechSci Research
  • ID: 5895880
UP TO OFF until Jul 31st 2025
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Mesenchymal Stem Cells Market was valued at USD 2.71 Billion in 2024, and is expected to reach USD 4.40 Billion by 2030, rising at a CAGR of 8.54%. This market is gaining traction due to rapid advancements in regenerative medicine, increased clinical trial activity, and rising awareness of the therapeutic potential of MSCs. Known for their ability to differentiate into various cell types such as bone, cartilage, and adipose tissues, MSCs have shown promise in treating a wide range of medical conditions.

Their immunomodulatory and anti-inflammatory properties, combined with low immunogenicity, make them suitable for applications in orthopedics, neurology, cardiology, and autoimmune diseases. Increasing research investments and favorable demographic trends, including an aging population with rising incidences of chronic conditions, are further propelling the market. The scope of MSC applications continues to broaden, encompassing emerging areas such as dermatology and oncology, while technological innovations and expanding clinical studies underline the potential for MSCs in both therapeutic and research domains.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The growing burden of chronic illnesses such as diabetes, cardiovascular diseases, neurodegenerative conditions, and arthritis is significantly driving demand for mesenchymal stem cell-based therapies. As these long-term diseases impose substantial health and economic burdens globally, MSCs offer a regenerative and immunomodulatory approach that addresses underlying tissue damage and inflammation. Their application in chronic disease management is supported by increasing interest in cell-based therapies that promote healing and reduce dependency on symptomatic treatments. The World Health Organization attributes approximately 71% of global deaths to chronic diseases, underscoring the urgent need for innovative therapies like MSCs, which are becoming integral to modern medical approaches.

Key Market Challenges

Regulatory Challenges

Navigating the regulatory environment presents a key challenge for the MSC market. Regulations vary significantly across regions, affecting the approval, manufacturing, and commercialization of MSC-based products. Adhering to Good Manufacturing Practices (GMP) and gaining regulatory approvals can be time-consuming and financially burdensome. The lack of globally harmonized standards also complicates market entry for developers and manufacturers. As the demand for MSC therapies rises, the development of streamlined and unified regulatory pathways will be critical to facilitating wider access and accelerating growth in the global market.

Key Market Trends

Technological Advancements

Technological innovations are transforming the MSC landscape, enabling more efficient and scalable production, enhanced therapeutic efficacy, and targeted delivery. Advances in bioreactor technology, 3D scaffolds, and microfluidic systems have improved the reproducibility and yield of MSC cultures. Tools like CRISPR-Cas9 are being used to genetically modify MSCs to enhance regenerative or immunological capabilities. Progress in biomaterials and drug delivery platforms allows for precise MSC deployment, improving clinical outcomes. Automation and robotic systems are streamlining MSC manufacturing, while imaging techniques like MRI and bioluminescent imaging provide real-time tracking of therapeutic cells. These advancements collectively support the expansion of MSC-based applications and ensure consistency in product quality, aiding in broader adoption across healthcare systems.

Key Market Players

  • Thermo Fisher Scientific, Inc
  • Cell Applications, Inc
  • Axol Biosciences Ltd
  • Cytori Therapeutics Inc
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen Inc
  • BrainStorm Cell Limited
  • Stemedica Cell Technologies Inc
  • Merck KGaA (MilliporeSigma)
  • PromoCell GmbH

Report Scope:

In this report, the Global Mesenchymal Stem Cells Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mesenchymal Stem Cells Market, By Product & Services:

  • Product
  • Services

Mesenchymal Stem Cells Market, By Workflow:

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

Mesenchymal Stem Cells Market, By Type:

  • Autologous
  • Allogeneic

Mesenchymal Stem Cells Market, By Source of Isolation:

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

Mesenchymal Stem Cells Market, By Indication:

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

Mesenchymal Stem Cells Market, By Application:

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cells Market, By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mesenchymal Stem Cells Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary4. Voice of Customer
5. Global Mesenchymal Stem Cells Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Services {Products (Cells & Cell Lines, Kits, Media, & Reagents, Others), Services}
5.2.2. By Workflow (Cell Sourcing & Isolation, Culture & Cryopreservation, Differentiation, Characterization)
5.2.3. By Type (Autologous, Allogeneic)
5.2.4. By Source of Isolation (Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal Liver, Lung, Adipose Tissues)
5.2.5. By Indication (Bone and Cartilage Repair, Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Others)
5.2.6. By Application (Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Others)
5.2.7. By Region
5.2.8. By Company (2024)
5.3. Market Map
6. North America Mesenchymal Stem Cells Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Services
6.2.2. By Workflow
6.2.3. By Type
6.2.4. By Source of Isolation
6.2.5. By Indication
6.2.6. By Application
6.2.7. By Country
6.3. North America: Country Analysis
6.3.1. United States Mesenchymal Stem Cells Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Services
6.3.1.2.2. By Workflow
6.3.1.2.3. By Type
6.3.1.2.4. By Source of Isolation
6.3.1.2.5. By Indication
6.3.1.2.6. By Application
6.3.2. Canada Mesenchymal Stem Cells Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Services
6.3.2.2.2. By Workflow
6.3.2.2.3. By Type
6.3.2.2.4. By Source of Isolation
6.3.2.2.5. By Indication
6.3.2.2.6. By Application
6.3.3. Mexico Mesenchymal Stem Cells Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Services
6.3.3.2.2. By Workflow
6.3.3.2.3. By Type
6.3.3.2.4. By Source of Isolation
6.3.3.2.5. By Indication
6.3.3.2.6. By Application
7. Europe Mesenchymal Stem Cells Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Services
7.2.2. By Workflow
7.2.3. By Type
7.2.4. By Source of Isolation
7.2.5. By Indication
7.2.6. By Application
7.2.7. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Mesenchymal Stem Cells Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Services
7.3.1.2.2. By Workflow
7.3.1.2.3. By Type
7.3.1.2.4. By Source of Isolation
7.3.1.2.5. By Indication
7.3.1.2.6. By Application
7.3.2. United Kingdom Mesenchymal Stem Cells Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Services
7.3.2.2.2. By Workflow
7.3.2.2.3. By Type
7.3.2.2.4. By Source of Isolation
7.3.2.2.5. By Indication
7.3.2.2.6. By Application
7.3.3. Italy Mesenchymal Stem Cells Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Product & Services
7.3.3.2.2. By Workflow
7.3.3.2.3. By Type
7.3.3.2.4. By Source of Isolation
7.3.3.2.5. By Indication
7.3.3.2.6. By Application
7.3.4. France Mesenchymal Stem Cells Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Services
7.3.4.2.2. By Workflow
7.3.4.2.3. By Type
7.3.4.2.4. By Source of Isolation
7.3.4.2.5. By Indication
7.3.4.2.6. By Application
7.3.5. Spain Mesenchymal Stem Cells Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Services
7.3.5.2.2. By Workflow
7.3.5.2.3. By Type
7.3.5.2.4. By Source of Isolation
7.3.5.2.5. By Indication
7.3.5.2.6. By Application
8. Asia-Pacific Mesenchymal Stem Cells Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Services
8.2.2. By Workflow
8.2.3. By Type
8.2.4. By Source of Isolation
8.2.5. By Indication
8.2.6. By Application
8.2.7. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Mesenchymal Stem Cells Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Services
8.3.1.2.2. By Workflow
8.3.1.2.3. By Type
8.3.1.2.4. By Source of Isolation
8.3.1.2.5. By Indication
8.3.1.2.6. By Application
8.3.2. India Mesenchymal Stem Cells Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Services
8.3.2.2.2. By Workflow
8.3.2.2.3. By Type
8.3.2.2.4. By Source of Isolation
8.3.2.2.5. By Indication
8.3.2.2.6. By Application
8.3.3. Japan Mesenchymal Stem Cells Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Services
8.3.3.2.2. By Workflow
8.3.3.2.3. By Type
8.3.3.2.4. By Source of Isolation
8.3.3.2.5. By Indication
8.3.3.2.6. By Application
8.3.4. South Korea Mesenchymal Stem Cells Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Services
8.3.4.2.2. By Workflow
8.3.4.2.3. By Type
8.3.4.2.4. By Source of Isolation
8.3.4.2.5. By Indication
8.3.4.2.6. By Application
8.3.5. Australia Mesenchymal Stem Cells Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Services
8.3.5.2.2. By Workflow
8.3.5.2.3. By Type
8.3.5.2.4. By Source of Isolation
8.3.5.2.5. By Indication
8.3.5.2.6. By Application
9. South America Mesenchymal Stem Cells Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Services
9.2.2. By Workflow
9.2.3. By Type
9.2.4. By Source of Isolation
9.2.5. By Indication
9.2.6. By Application
9.2.7. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Mesenchymal Stem Cells Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Services
9.3.1.2.2. By Workflow
9.3.1.2.3. By Type
9.3.1.2.4. By Source of Isolation
9.3.1.2.5. By Indication
9.3.1.2.6. By Application
9.3.2. Argentina Mesenchymal Stem Cells Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Services
9.3.2.2.2. By Workflow
9.3.2.2.3. By Type
9.3.2.2.4. By Source of Isolation
9.3.2.2.5. By Indication
9.3.2.2.6. By Application
9.3.3. Colombia Mesenchymal Stem Cells Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Services
9.3.3.2.2. By Workflow
9.3.3.2.3. By Type
9.3.3.2.4. By Source of Isolation
9.3.3.2.5. By Indication
9.3.3.2.6. By Application
10. Middle East and Africa Mesenchymal Stem Cells Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Services
10.2.2. By Workflow
10.2.3. By Type
10.2.4. By Source of Isolation
10.2.5. By Indication
10.2.6. By Application
10.2.7. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Mesenchymal Stem Cells Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Services
10.3.1.2.2. By Workflow
10.3.1.2.3. By Type
10.3.1.2.4. By Source of Isolation
10.3.1.2.5. By Indication
10.3.1.2.6. By Application
10.3.2. Saudi Arabia Mesenchymal Stem Cells Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Services
10.3.2.2.2. By Workflow
10.3.2.2.3. By Type
10.3.2.2.4. By Source of Isolation
10.3.2.2.5. By Indication
10.3.2.2.6. By Application
10.3.3. UAE Mesenchymal Stem Cells Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product & Services
10.3.3.2.2. By Workflow
10.3.3.2.3. By Type
10.3.3.2.4. By Source of Isolation
10.3.3.2.5. By Indication
10.3.3.2.6. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments
13. Global Mesenchymal Stem Cells Market: SWOT Analysis
14. Competitive Landscape
14.1. Thermo Fisher Scientific, Inc
14.1.1. Business Overview
14.1.2. Age Group Offerings
14.1.3. Recent Developments
14.1.4. Key Personnel
14.1.5. SWOT Analysis
14.2. Cell Applications, Inc
14.3. Axol Biosciences Ltd
14.4. Cytori Therapeutics Inc
14.5. STEMCELL Technologies
14.6. Cyagen Biosciences
14.7. Celprogen Inc
14.8. BrainStorm Cell Limited
14.9. Stemedica Cell Technologies Inc
14.10. Merck KGaA (MilliporeSigma)
14.11. PromoCell GmbH
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

  • Thermo Fisher Scientific, Inc
  • Cell Applications, Inc
  • Axol Biosciences Ltd
  • Cytori Therapeutics Inc
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen Inc
  • BrainStorm Cell Limited
  • Stemedica Cell Technologies Inc
  • Merck KGaA (MilliporeSigma)
  • PromoCell GmbH

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.4 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Mesenchymal Stem Cells Market Report 2025 - Product Image

Mesenchymal Stem Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Mesenchymal Stem Cells (MSC) - Global Strategic Business Report - Product Image

Mesenchymal Stem Cells (MSC) - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From
Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2025 - Product Image

Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2025

  • Report
  • 381 Pages
  • Global
From
Mesenchymal Stem Cells Market by Application, Source, End User, Product Type, Culture Method, Therapy Type - Global Forecast to 2030 - Product Image

Mesenchymal Stem Cells Market by Application, Source, End User, Product Type, Culture Method, Therapy Type - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.